Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Der Pathologe|August 17, 2010
[Molecular mechanisms of progression in human hepatocarcinogenesis]K Breuhahn
Progress in Molecular Biology and Translational Science|November 16, 2010
Signaling networks in human hepatocarcinogenesis--novel aspects and therapeutic optionsK Breuhahn, P Schirmacher
Oncogene|June 27, 2006
Dysregulation of growth factor signaling in human hepatocellular carcinomaK Breuhahn, T Longerich, P Schirmacher
The Journal of Investigative Dermatology|March 12, 2002
Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularizationA Mann, K Breuhahn, P Schirmacher, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 5, 2008
[Reduced expression of the E3-ubiquitin ligase seven in absentia homologue (SIAH)-1 in human hepatocellular carcinoma]A Brauckhoff, V Ehemann, P Schirmacher, et al.
British Journal of Cancer|March 10, 2005
Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysisP Moinzadeh, K Breuhahn, H Stützer, et al.
The Journal of Pathology|May 21, 2008
Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesisK Breuhahn, S Singh, P Schirmacher, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 5, 2008
[Insulin-like growth factor (IGF)-signalling pathway components are potential therapeutic targets in the treatment of human hepatocellular carcinoma]T Nussbaum, J Samarin, P Schirmacher, et al.
Der Pathologe|July 3, 2007
[Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology]M A Kern, K Breuhahn, M Schuchmann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?]T Nussbaum, S Vreden, M Farsad, et al.
Pageof 3